In the skin, kallikrein‐related peptidases are controlled by SPINK5 and unopposed kallikrein‐peptidase activity due to SPINK5 deficiency leads to Netherton syndrome, a severe skin disease (Furio & Hovnanian, 2014). Here, LAP3 is linked to Netherton syndrome.